Anticholinergics in asthma: are we utilizing asthma therapies effectively?

Christian Vogelberg Department of Pediatric Pulmonology and Allergy, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, GermanyData have shown that asthma is the most prevalent chronic respiratory disease, affecting 358 million people worldwide in 2015.1 While...

Full description

Bibliographic Details
Main Author: Vogelberg C
Format: Article
Language:English
Published: Dove Medical Press 2019-03-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Online Access:https://www.dovepress.com/anticholinergics-in-asthma-are-we-utilizing-asthma-therapies-effective-peer-reviewed-article-TCRM
_version_ 1819141061225742336
author Vogelberg C
author_facet Vogelberg C
author_sort Vogelberg C
collection DOAJ
description Christian Vogelberg Department of Pediatric Pulmonology and Allergy, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, GermanyData have shown that asthma is the most prevalent chronic respiratory disease, affecting 358 million people worldwide in 2015.1 While data show that the age-standardized asthma-related death rate decreased by 58.8% from 1990–2015,1 asthma still represents a significant burden in terms of morbidity.2 As such, there is an important role for utilizing add-on therapy options. The focus of this review series is on the use of long-acting anticholinergic add-on therapy to reduce asthma morbidity.
first_indexed 2024-12-22T11:48:27Z
format Article
id doaj.art-c725bb8fd2dd486994b01207ae4cca9a
institution Directory Open Access Journal
issn 1178-203X
language English
last_indexed 2024-12-22T11:48:27Z
publishDate 2019-03-01
publisher Dove Medical Press
record_format Article
series Therapeutics and Clinical Risk Management
spelling doaj.art-c725bb8fd2dd486994b01207ae4cca9a2022-12-21T18:27:05ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2019-03-01Volume 1540540844584Anticholinergics in asthma: are we utilizing asthma therapies effectively?Vogelberg CChristian Vogelberg Department of Pediatric Pulmonology and Allergy, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, GermanyData have shown that asthma is the most prevalent chronic respiratory disease, affecting 358 million people worldwide in 2015.1 While data show that the age-standardized asthma-related death rate decreased by 58.8% from 1990–2015,1 asthma still represents a significant burden in terms of morbidity.2 As such, there is an important role for utilizing add-on therapy options. The focus of this review series is on the use of long-acting anticholinergic add-on therapy to reduce asthma morbidity.https://www.dovepress.com/anticholinergics-in-asthma-are-we-utilizing-asthma-therapies-effective-peer-reviewed-article-TCRMasthmaanticholinergictiotropiumadultchildrenpreschool childreninhaler
spellingShingle Vogelberg C
Anticholinergics in asthma: are we utilizing asthma therapies effectively?
Therapeutics and Clinical Risk Management
asthma
anticholinergic
tiotropium
adult
children
preschool children
inhaler
title Anticholinergics in asthma: are we utilizing asthma therapies effectively?
title_full Anticholinergics in asthma: are we utilizing asthma therapies effectively?
title_fullStr Anticholinergics in asthma: are we utilizing asthma therapies effectively?
title_full_unstemmed Anticholinergics in asthma: are we utilizing asthma therapies effectively?
title_short Anticholinergics in asthma: are we utilizing asthma therapies effectively?
title_sort anticholinergics in asthma are we utilizing asthma therapies effectively
topic asthma
anticholinergic
tiotropium
adult
children
preschool children
inhaler
url https://www.dovepress.com/anticholinergics-in-asthma-are-we-utilizing-asthma-therapies-effective-peer-reviewed-article-TCRM
work_keys_str_mv AT vogelbergc anticholinergicsinasthmaareweutilizingasthmatherapieseffectively